Dexmedetomidine Infusion Perioperative to Control Agitation in Non-intubated Young Patient with Cystic Fibrosis Undergoing Upper Arm Ultrasound Guided Totally Implantable Port-A-Cath Placement: A Case Report
Untreated anxiety can lead to difficult induction, increased postoperative pain, greater analgesic requirements, emergence agitation and even postoperative psychological effects and behavioral issue. The Dexmedetomidine [DMET] could be an effective sedative analgesic agent for analgesia peri-operative management in young patients anxious and agitated, with “difficult of ventilation and intubation”, undergoing brief and minimally invasive surgical procedures without the need of tracheal intubation. We described a case of successfully used the Dexmedetomidine for sedation and analgesia during ultrasound guided percutaneous right arm Port-A-Cath device implantation in agitation young patient affected by cystic fibrosis with respiratory failure. The aim of this case report was evaluate the effectiveness and efficiency of the use of dexmedetomidine on the peri-operative and postoperative period. We observed that the DMET improved the effects of local anesthetics and its determined sedation, anxiolysis and analgesia with a more comfortable and effective management during mini-invasive procedure and excellent patient satisfaction. In the postoperative period the patient showed better oxygenation, excellent anxious control and good pain management.